UNSPSC 51386004: Butanixin

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51386004

Definition

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FZ99TBX0LI. European Medicines Agency schedules Butanixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06004MIG. Butanixin generally arises in the molecular formula C16H18N2O2.

Read the full definition

The term BUTANIXIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, no. 10 1975, list 15.) BUTANIXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butanixin under HS 29333999 and SITC 51574. As of Q4 2014, BUTANIXIN remains the US FDA Preferred Term for this commodity. Butanixin bears US NLM identifiers UMLS ID C2347238 and NCI Concept Code C73082. SMILES: OC(=O)C1C(NC2CC(CCCC)CCC2)NCCC1.

About UNSPSC 51386004

UNSPSC 51386004 Butanixin is a Commodity code, but state and local procurement activity under this code shows little alignment with its nominal scope. The single recent opportunity posted in the source—Seminole County, Florida's IFB for naloxone and drug deactivation systems—does not represent butanixin procurement. Naloxone (an opioid antagonist) and drug deactivation systems serve community health and harm-reduction missions, which differ materially from butanixin's pharmaceutical classification. The mismatch suggests either a data-entry error in the code assignment or that state and local governments do not currently solicit butanixin under this taxonomy. Without additional recent opportunities demonstrating actual butanixin purchasing patterns, the code's current relevance to state and local business development efforts cannot be assessed.

Seminole County's July 2026 IFB (IFB60459723LAS, response deadline July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-Procurement Portal, included all shipping and delivery costs, and carried a two-year initial term with a one-year renewal option. Bidders faced standard state and local compliance requirements—drug-free workplace certification, E-Verify enrollment, workers' compensation and commercial general liability insurance, and potential FEMA-related federal compliance obligations. The absence of recent opportunities genuinely tagged to butanixin procurement signals that this code tier sees minimal current state and local buying activity; vendors should verify current code assignments and market demand before committing resources to pursuit under this taxonomy.

Quick answers

What is UNSPSC 51386004?

UNSPSC 51386004 is Butanixin, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51386004?

UNSPSC 51386004 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51386004

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code